Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Van Cutsem

Showing results (111-120 of 251) with videos related to

Pageof 26
Sort By:
British Journal of Cancer|July 5, 2001
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)S Tejpar, C Li, C Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study GroupG Cocconi, D Cunningham, E Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancerP Flamen, S Stroobants, E Van Cutsem, et al.
Gastroenterologie Clinique Et Biologique|September 2, 1999
Different gastritis features are linked to different gastric neoplasmsA Driessen, N Ectors, E Van Cutsem, et al.
Acta Gastro-Enterologica Belgica|March 19, 2022
Prevalence of microsatellite instable and Epstein-Barr Virus-driven gastroesophageal cancer in a large Belgian cohortS De Meulder, X Sagaert, H Brems, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
ZD1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer. Tomudex Colorectal Study GroupJ R Zalcberg, D Cunningham, E Van Cutsem, et al.
Acta Gastro-Enterologica Belgica|February 24, 2001
Curative management of adenocarcinoma of the oesophagus and oesogastric junction--current recommendations of the Belgian Working GroupJ L Van Laethem, F Baert, M Buset, et al.
Investigational New Drugs|April 6, 2006
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxaneJ A Ajani, H Safran, C Bokemeyer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2005
Chemo-radiotherapy versus radiotherapy alone in the pre-operative treatment of resectable rectal cancerL Goethals, K Haustermans, C Perneel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2007
A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patientsE Van Cutsem, C Verslype, P Beale, et al.
Pageof 26

Showing results (111-120 of 251) with videos related to

Sort By:
Pageof 26
British Journal of Cancer|July 5, 2001
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)S Tejpar, C Li, C Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study GroupG Cocconi, D Cunningham, E Van Cutsem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancerP Flamen, S Stroobants, E Van Cutsem, et al.
Gastroenterologie Clinique Et Biologique|September 2, 1999
Different gastritis features are linked to different gastric neoplasmsA Driessen, N Ectors, E Van Cutsem, et al.
Acta Gastro-Enterologica Belgica|March 19, 2022
Prevalence of microsatellite instable and Epstein-Barr Virus-driven gastroesophageal cancer in a large Belgian cohortS De Meulder, X Sagaert, H Brems, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
ZD1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer. Tomudex Colorectal Study GroupJ R Zalcberg, D Cunningham, E Van Cutsem, et al.
Acta Gastro-Enterologica Belgica|February 24, 2001
Curative management of adenocarcinoma of the oesophagus and oesogastric junction--current recommendations of the Belgian Working GroupJ L Van Laethem, F Baert, M Buset, et al.
Investigational New Drugs|April 6, 2006
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxaneJ A Ajani, H Safran, C Bokemeyer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2005
Chemo-radiotherapy versus radiotherapy alone in the pre-operative treatment of resectable rectal cancerL Goethals, K Haustermans, C Perneel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2007
A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patientsE Van Cutsem, C Verslype, P Beale, et al.
Pageof 26